Search
for
Sort by
Research 601–630 of 613
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
- The Important Role of Leptin in Modulating the Risk of Dermatological Diseases
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- The Role of Probiotics and Synbiotics on Hirsutism
- Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome
- Isoginkgetin, a natural biflavonoid from Ginkgo biloba, inhibits inflammatory response in endothelial cells via suppressing NF-κB activation
- The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
- AN OVERVIEW ON POLYCYSTIC OVARIAN SYNDROME
- The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)
- Hyper-Androgenic Symptoms and Infertility in Northern Upper Egypt: Impact of Lifestyle Modification
- PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
- A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries
- Is the severity of alopecia areata associated with arterial stiffness?
- Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome
- The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective
- Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health
- A practical guide on Polyendocrine Metabolic Ovarian Syndrome (PMOS) for Clinicians
- BH03 Comorbidities in patients with frontal fibrosing alopecia: a systematic review and meta-analysis of associated conditions
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Workup and Management of Polycystic Ovary Syndrome
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Metabolic risk in PCOS: phenotype and adiposity impact
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome